siku kupa - Gender Studies bibliographies - in Harvard style

In-text: (Contin et al., 1991)

Your Bibliography: Contin, M., Riva, R., Martinelli, P., Procaccianti, G., Albani, F. and Baruzzi, A., 1991. Combined Levodopa-Anticholinergic Therapy in the Treatment of Parkinsonʼs Disease Effect on Levodopa Bioavailability. Clinical Neuropharmacology, 14(2), pp.148-155.

In-text: (Coupland et al., 2019)

Your Bibliography: Coupland, C., Hill, T., Dening, T., Morriss, R., Moore, M. and Hippisley-Cox, J., 2019. Anticholinergic Drug Exposure and the Risk of Dementia. JAMA Internal Medicine, 179(8), p.1084.

In-text: (Isaacson and Skettini, 2014)

Your Bibliography: Isaacson, S. and Skettini, J., 2014. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa. Vascular Health and Risk Management, p.169.

In-text: (Parkes et al., 1976)

Your Bibliography: Parkes, J., Marsden, C., Donaldson, I., Galea-Debono, A., Walters, J., Kennedy, G. and Asselman, P., 1976. Bromocriptine treatment in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 39(2), pp.184-193.

In-text: (Riederer and Laux, 2011)

Your Bibliography: Riederer, P. and Laux, G., 2011. MAO-inhibitors in Parkinson's Disease. Experimental Neurobiology, 20(1), pp.1-17.

In-text: (Starkstein and Brockman, 2017)

Your Bibliography: Starkstein, S. and Brockman, S., 2017. Management of Depression in Parkinson's Disease: A Systematic Review. Movement Disorders Clinical Practice, 4(4), pp.470-477.

In-text: (Zhang et al., 2017)

Your Bibliography: Zhang, H., Bai, L., He, J., Zhong, L., Duan, X., Ouyang, L., Zhu, Y., Wang, T., Zhang, Y. and Shi, J., 2017. Recent advances in discovery and development of natural products as source for anti-Parkinson's disease lead compounds. European Journal of Medicinal Chemistry, 141, pp.257-272.